HARVARD BIOSCIENCE, INC. Deferred Foreign Income Tax Expense (Benefit)
HARVARD BIOSCIENCE, INC. (HBIO) reported Deferred Foreign Income Tax Expense (Benefit) of -$122.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-03-13
- HARVARD BIOSCIENCE, INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$122.00K, a 132.11% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. deferred foreign income tax expense (benefit) for fiscal 2024 was $380.00K, a 295.83% increase from fiscal 2023.
- HARVARD BIOSCIENCE, INC. deferred foreign income tax expense (benefit) for fiscal 2023 was $96.00K.
- HARVARD BIOSCIENCE, INC. deferred foreign income tax expense (benefit) for fiscal 2022 was -$30.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$122.00K 10-K · filed 2026-03-13 |
| 2024-12-31 | $380.00K 10-K · filed 2026-03-13 |
| 2023-12-31 | $96.00K 10-K · filed 2025-03-14 |
| 2022-12-31 | -$30.00K 10-K · filed 2024-03-07 |
| 2021-12-31 | -$393.00K 10-K · filed 2023-03-09 |
| 2020-12-31 | -$388.00K 10-K · filed 2022-03-11 |
| 2019-12-31 | -$117.00K 10-K/A · filed 2021-03-17 |
| 2018-12-31 | -$212.00K 10-K · filed 2020-03-16 |
| 2017-12-31 | $575.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $103.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | -$840.00K 10-K · filed 2018-03-16 |
| 2014-12-31 | -$182.00K 10-K · filed 2017-03-17 |
| 2013-12-31 | -$154.00K 10-K · filed 2016-04-29 |
| 2012-12-31 | -$308.00K 10-K · filed 2015-03-12 |
| 2011-12-31 | -$166.00K 10-K · filed 2014-03-14 |
| 2010-12-31 | -$258.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |